Causalis vs CytoReason
Causalis vs CytoReason, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Causalis is on 40/100 and CytoReason on 68/100.
Where each one leads
Causalis
- agent readiness: 38/100 against 21/100
CytoReason
- our overall score: 68/100 against 40/100
- domain rating: 40/100 against 1/100
- headcount: 116 against 2
- LinkedIn following: 12,830 against 369
At a glance
| Measure | Causalis | CytoReason |
|---|---|---|
| What it is | Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Data, Causal Inference, HealthTech | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2020 | 2016 |
| Headquarters | Not published | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Causalis | CytoReason |
|---|---|---|
| Employees | 2 | 116 |
| Headcount growthLast 12 months | Not published | +13.7% |
| Total funding | Not published | $128M |
| Latest round | Seed | Series B |
| LinkedIn followers | 369 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Causalis | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 40/100 | 68/100 |
| Traction | 6/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 32/100 | 30/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 1/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Causalis | CytoReason |
|---|---|---|
| Analytics | Not detected | Segment |
Causalis vs CytoReason: common questions
Which is better, Causalis or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Causalis and CytoReason compare on the numbers?
Causalis leads on agent readiness (38/100 against 21/100). CytoReason leads on our overall score (68/100 against 40/100), domain rating (40/100 against 1/100), headcount (116 against 2), LinkedIn following (12,830 against 369).
Read the full Causalis review and pricing or the CytoReason review and pricing. You can also browse other Causalis alternatives we track.